Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

Similar articles for PubMed (Select 19961137)

1.

Drug-eluting coronary artery stents.

Dehmer GJ, Smith KJ.

Am Fam Physician. 2009 Dec 1;80(11):1245-51.

2.

Drug-eluting coronary stents: many meta-analyses, little benefit.

[No authors listed]

Prescrire Int. 2009 Apr;18(100):70-4.

PMID:
19585727
3.

[Care of patients after coronary stent implantation: what is important in practice?].

Schächinger V.

Internist (Berl). 2007 Dec;48(12):1365-74. Review. German.

PMID:
17992495
4.

[Stents in interventional cardiology].

Grinius V, Navickas R, Unikas R.

Medicina (Kaunas). 2007;43(3):183-9. Review. Lithuanian.

5.

[Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].

Koziński M, Sukiennik A, Sinkiewicz W, Kochman W, Kubica J.

Postepy Hig Med Dosw (Online). 2008 May 8;62:185-205. Review. Polish.

6.

Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.

Rossini R, Musumeci G, Aprile A, Valsecchi O.

Expert Rev Pharmacoecon Outcomes Res. 2010 Feb;10(1):49-61. doi: 10.1586/erp.10.1. Review.

PMID:
20121564
7.

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.

Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM; TRITON-TIMI 38 Investigators.

Lancet. 2008 Apr 19;371(9621):1353-63. doi: 10.1016/S0140-6736(08)60422-5. Epub 2008 Apr 2.

PMID:
18377975
8.

[Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?].

Baer FM, Erdmann E.

Dtsch Med Wochenschr. 2007 Jun 8;132(23):1275-80. Review. German.

PMID:
17541871
9.

Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.

Newsome LT, Kutcher MA, Royster RL.

Anesth Analg. 2008 Aug;107(2):552-69. doi: 10.1213/ane.0b013e3181732049. Review.

PMID:
18633035
10.

[Optimal platelet inhibition after coronary stent implantation. Current status].

Silber S, Hoffmeister HM, Bode C.

Herz. 2008 Jun;33(4):244-53. doi: 10.1007/s00059-008-3138-9. Review. German.

PMID:
18581073
11.

Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.

Moussa ID, Colombo A.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1047-54. doi: 10.1002/ccd.22167. Review.

PMID:
19626692
12.

Drug-eluting stent thrombosis.

Stähli BE, Camici GG, Tanner FC.

Ther Adv Cardiovasc Dis. 2009 Feb;3(1):45-52. doi: 10.1177/1753944708096280. Epub 2008 Sep 18. Review.

PMID:
19124388
13.

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ.

Circulation. 2006 Jun 20;113(24):2803-9. Epub 2006 Jun 12.

14.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
15.

[Late thrombosis in paclitaxel-eluting stent after discontinuation of clopidogrel medication - a case report with 2-year follow-up].

Wozakowska-Kapłon B, Młodnicki M, Gutkowski W.

Kardiol Pol. 2009 Mar;67(3):299-303; discussion 304. Polish.

16.
17.

Late coronary thrombosis in paclitaxel-eluting stents. Case reports.

Cassin M, De Biasio M, Macor F, Burelli C, Vendrametto F, Driussi M, Nicolosi GL.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):284-8.

PMID:
17413307
18.

Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?

Kumbhani DJ, Bavry AA, Bhatt DL.

Indian Heart J. 2007 Mar-Apr;59(2 Suppl B):B113-7. Review.

PMID:
19153427
20.

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.

Byrne RA, Schulz S, Mehilli J, Iijima R, Massberg S, Neumann FJ, ten Berg JM, Schömig A, Kastrati A; Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Investigators.

Am Heart J. 2009 Apr;157(4):620-4.e2. doi: 10.1016/j.ahj.2008.12.019.

PMID:
19332187
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk